Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

West Pharmaceutical Services (WST)

West Pharmaceutical Services (WST)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,524,097
  • Shares Outstanding, K 73,991
  • Annual Sales, $ 1,717 M
  • Annual Income, $ 206,900 K
  • 60-Month Beta 1.24
  • Price/Sales 6.55
  • Price/Cash Flow 36.68
  • Price/Book 7.79

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.72
  • Number of Estimates 4
  • High Estimate 0.73
  • Low Estimate 0.70
  • Prior Year 0.73
  • Growth Rate Est. (year over year) -1.37%

Price Performance

See More
Period Period Low Period High Performance
1-Month
148.72 +4.73%
on 01/03/20
159.21 -2.17%
on 01/17/20
+5.02 (+3.33%)
since 12/24/19
3-Month
138.46 +12.49%
on 10/25/19
159.21 -2.17%
on 01/17/20
+16.89 (+12.16%)
since 10/24/19
52-Week
98.60 +57.96%
on 02/14/19
159.21 -2.17%
on 01/17/20
+50.29 (+47.69%)
since 01/24/19

Most Recent Stories

More News
Masimo Posts Solid Preliminary 2019 Results, Issues Guidance

Higher revenues and upbeat 2020 outlook benefit Masimo's (MASI) preliminary full-year 2019 results.

MASI : 169.08 (-0.54%)
XRAY : 59.66 (unch)
PDCO : 23.35 (-0.81%)
WST : 155.75 (-0.51%)
Here's Why You Should Add Bruker (BRKR) to Your Portfolio Now

Investor confidence in Bruker (BRKR) is at a high, thanks to solid prospects.

OMCL : 84.05 (-2.44%)
BRKR : 52.40 (-0.80%)
HAE : 107.45 (-2.37%)
WST : 155.75 (-0.51%)
5 Promising Growth Stocks in MedTech to Invest in 2020

We have zeroed in on five impressive growth stocks in MedTech on the back of the industry's lucrative prospects.

HMSY : 27.00 (-3.88%)
CERN : 74.46 (-1.61%)
OMCL : 84.05 (-2.44%)
LHCG : 146.73 (-0.63%)
WST : 155.75 (-0.51%)
Watch for West Pharmaceut to Potentially Pullback After Gaining 1.15% Yesterday

West Pharmaceut (NYSE:WST) traded in a range yesterday that spanned from a low of $152.82 to a high of $155.26. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of...

WST : 155.75 (-0.51%)
Baxter Posts Upbeat Q4 Preliminary Results, Issues Guidance

Higher revenues, growth in all geographic segments and six business units benefit Baxter's (BAX) Q4 preliminary operating results.

BAX : 90.78 (-0.35%)
PDCO : 23.35 (-0.81%)
WST : 155.75 (-0.51%)
XRAY : 59.66 (unch)
Here's Why You Should Hold on to Cardinal Health Stock Now

Cardinal Health (CAH) is gaining from diversified product portfolio and robust pharmaceutical segment. However, integration risks remain a concern.

PDCO : 23.35 (-0.81%)
WST : 155.75 (-0.51%)
XRAY : 59.66 (unch)
CAH : 53.82 (-1.91%)
PDCO or WST: Which Is the Better Value Stock Right Now?

PDCO vs. WST: Which Stock Is the Better Value Option?

PDCO : 23.35 (-0.81%)
WST : 155.75 (-0.51%)
Intuitive Surgical (ISRG) Up on Solid Preliminary Q4 Results

Higher revenues and growth in worldwide da Vinci procedure volume benefit Intuitive Surgical's (ISRG) preliminary Q4 results.

ISRG : 589.20 (-4.20%)
PDCO : 23.35 (-0.81%)
WST : 155.75 (-0.51%)
XRAY : 59.66 (unch)
Veeva Systems Boosts Product Portfolio With New Application

Veeva Systems (VEEV) introduces Veeva Vault Payments, which is likely to bolster the company's already robust product portfolio.

VEEV : 145.19 (-0.26%)
PDCO : 23.35 (-0.81%)
XRAY : 59.66 (unch)
WST : 155.75 (-0.51%)
Varian (VAR) Hits a 52-Week High: What's Driving the Stock?

Varian (VAR) gains from several positive developments.

OMCL : 84.05 (-2.44%)
VAR : 148.29 (-0.75%)
HAE : 107.45 (-2.37%)
WST : 155.75 (-0.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade WST with:

Business Summary

West Pharmaceutical Services, Inc. is a global drug delivery technology company that applies proprietary materials science, formulation research and manufacturing innovation to advance the quality, therapeutic value, development speed and rapid market availability of pharmaceuticals, biologics, vaccines...

See More

Key Turning Points

2nd Resistance Point 158.01
1st Resistance Point 156.88
Last Price 155.75
1st Support Level 154.97
2nd Support Level 154.19

See More

52-Week High 159.21
Last Price 155.75
Fibonacci 61.8% 136.06
Fibonacci 50% 128.90
Fibonacci 38.2% 121.75
52-Week Low 98.60

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar